|
DHX57 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66233693477125E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.85299586575161E-11 |
| Normal-vs-Stage2 |
4.66329999948556E-07 |
| Normal-vs-Stage3 |
2.6896262994569E-12 |
| Normal-vs-Stage4 |
1.89814830520163E-12 |
| Stage1-vs-Stage2 |
7.926800E-01 |
| Stage1-vs-Stage3 |
8.160200E-02 |
| Stage1-vs-Stage4 |
1.622750E-03 |
| Stage2-vs-Stage3 |
3.532200E-01 |
| Stage2-vs-Stage4 |
5.766300E-02 |
| Stage3-vs-Stage4 |
1.736250E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.09592368302947E-14 |
| Normal-vs-AfricanAmerican |
1.615440E-03 |
| Normal-vs-Asian |
1.65350000358444E-09 |
| Caucasian-vs-AfricanAmerican |
1.223200E-01 |
| Caucasian-vs-Asian |
7.461400E-01 |
| AfricanAmerican-vs-Asian |
1.044640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.93219884536688E-11 |
| Normal-vs-Female |
1.9382273563906E-12 |
| Male-vs-Female |
8.160800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.07600039989109E-10 |
| Normal-vs-Age(41-60Yrs) |
4.02133881749478E-12 |
| Normal-vs-Age(61-80Yrs) |
5.32339727854492E-11 |
| Normal-vs-Age(81-100Yrs) |
1.661130E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.318000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.342000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.411200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.505800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.905600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.705600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.323080E-03 |
| Classical-VS-Follicular |
3.463600E-01 |
| Classical-VS-Other |
4.402600E-01 |
| Classical-VS-Normal |
7.47757411545535E-12 |
| Tall-VS-Follicular |
1.880170E-02 |
| Tall-VS-Other |
3.571600E-01 |
| Tall-VS-Normal |
2.35067521003884E-12 |
| Follicular-VS-Other |
7.524000E-01 |
| Follicular-VS-Normal |
2.13559999684421E-08 |
| Other-VS-Normal |
2.156300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.32459656763263E-11 |
| Normal-vs-N1 |
1.54354307113636E-12 |
| N0-vs-N1 |
3.395600E-02 |
|
|
